Zack Nigogosyan

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combination with standard chemotherapy for patients with advanced, inoperable pancreatic adenocarcinoma: a phase 1b observational study”.

Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combination with standard chemotherapy for patients with advanced, inoperable pancreatic adenocarcinoma: a phase 1b observational study

Cancer & Metabolism(2023)10.1186/s40170-023-00306-2

N/A

0.947DataRank · unranked

30 citations

Kian‐Huat Lim, J. L. Volkman, Mina Abdiannia, Hannah Johnston, Zack Nigogosyan +13 more

Factors associated with lack of care engagement among older, rural‐dwelling adults living with HIV in the United States

The Journal of Rural Health(2022)10.1111/jrh.12732

N/A

0DataRank · unranked

15 citations

Katherine Quinn, Steven A. John, Zack Nigogosyan, Jennifer L. Walsh, Andrew E. Petroll